Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
28/05/2026 07:35
BRIEF-Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln May 28 (Reuters) - ExpreS2ion Biotech Holding AB EXPRS2.ST:
Q1 2026 OPERATING INCOME SEK 6.87 MILLION
Q1 2026 LOSS AFTER FINANCIAL ITEMS SEK 12.06 MILLION
Source text: ID:nMFN8jgmhR
Further company coverage: EXPRS2.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on ExpreS2ion Biotech Holding AB
See all newsBrief: Expres2ion Biotech To Raise SEK 19.3 Million From Warrants And Share Issue
Brief: ExpreS2ion Reports Q2 Loss Of SEK 9.7 Million
Brief: Expres2ion Biotech Says DSMB Recommends Expanding 450 Μg Cohort
Brief: Expres2ion Biotech Holding Q1 2026 Operating Income SEK 6.87 Mln
Brief: Expres2ion Updates ES2B-C001 Phase I Programme and Reports Additional Preliminary Immunogenicity and Safety Observations